1022 Sleep in Duchenne Muscular Dystrophy

Dominique Low,Partha Ghosh MD

DOI: https://doi.org/10.1093/sleep/zsae067.01022

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction Duchenne Muscular Dystrophy (DMD), the prevalent childhood-onset muscular dystrophy, affects 1 in 3500 males due to a mutation in the DMD gene, leading to compromised dystrophin production and resultant muscle weakness. Steroid therapies, including prednisolone and deflazacort, commonly used in DMD treatment, may contribute to weight gain. Patients with DMD frequently experience sleep symptoms or disorders, particularly sleep-disordered breathing, impacting their quality of life. Methods The objective of this chart review of DMD patients in a multi-disciplinary DMD clinic at a tertiary referral center over a 3-month period is to estimate from the most recent notes, particularly the neurology and pulmonary notes, the prevalence of sleep symptoms and disorders in our multidisciplinary clinic. Clinical observations were also made and recorded by the investigators in the neuromuscular division of the DMD multidisciplinary clinic. Results Of the 29 patients reviewed, the average age was 13.3 (SD 3.8) years. All of the patients were male. The racial groups the patients identified as were: 11 (37.9%) “White,” 3 (10.3%) “Black or African American,” 2 (6.9%) “Asian,” 8 (27.6%) “Other,” and 5 (17.2%) “Declined to Answer.” The average BMI was 24.7 (SD 5.3). Of the 29 patients reviewed, 18 (62.1%) exhibited sleep symptoms or disorders. Of these 18 patients, 6 (33.3%) were treated with CPAP or BiPAP. Conclusion Our findings align with existing literature, emphasizing the prevalence of sleep-related symptoms and disorders in DMD patients. As DMD management progresses and treatment options expand, resulting in increased life expectancy, addressing sleep-related challenges becomes imperative to enhance the overall quality of life for these individuals. Further research is essential to delve into the intricate relationship between DMD and potential sleep co-morbidities, guiding interventions that can positively influence clinical trajectories and improve overall quality of life. Support (if any)

neurosciences,clinical neurology